research use only
Cat.No.S6990
| Related Targets | PD-1/PD-L1 CXCR STING AhR CD markers Interleukins Anti-infection Antioxidant COX Histamine Receptor |
|---|---|
| Other Immunology & Inflammation related Inhibitors | Cl-amidine Bestatin (Ubenimex) Bindarit (AF 2838) Tranilast Tempol Sinomenine GI254023X (GI4023) ATP Geniposidic acid CORM-3 |
|
In vitro |
Water : 100 mg/mL
DMSO
: Insoluble
Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | N/A | Formula | N/A |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 9008-97-3 | -- | Storage of Stock Solutions |
|
|
| Targets/IC50/Ki |
Bax
caspases-3
|
|---|---|
| In vitro |
Stimulation of human mononuclear leukocytes (MNL) by phytohemagglutinin (PHA) induces the expression of ChAT mRNA and potentiated ACh synthesis. This compound binds to the membranes of T-cells, stimulates metabolic activity, cell division, and involves inflammatory pathways. |
| In vivo |
Phytohemagglutinin (PHA), a standard T cell mitogen, can inhibit both T- and B-cell tumors. This compound (100 μg; i.p.; daily for 2 days) inhibits A20 tumor growth in CB17-SCID mice. |
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05968170 | Not yet recruiting | Graft Vs Host Disease|Graft-versus-host-disease|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Non-hematologic Malignancy|Hematologic Malignancy |
Neena Kapoor M.D.|Children''s Hospital Los Angeles |
December 1 2023 | Not Applicable |
| NCT05636995 | Recruiting | Primary Hyperaldosteronism|Hypertensive Disorder of Pregnancy |
Université de Sherbrooke|Foundation of the Stars |
January 10 2023 | -- |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.